Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
Dedee Murrell
,
Branka Marinovic
,
Frédéric Caux
(1)
,
Catherine Prost
,
Razzaque Ahmed
,
Katarzyna Wozniak
,
Masayuki Amagai
,
Johann Bauer
,
Stefan Beissert
(2)
,
Luca Borradori
(3)
,
Donna Culton
,
Janet Fairley
,
David Fivenson
,
Marcel Jonkman
,
M Peter Marinkovich
,
David Woodley
,
John Zone
,
Valeria Aoki
,
Philippe Bernard
(4)
,
Leena Bruckner-Tuderman
(5)
,
Giuseppe Cianchini
,
Vanessa Venning
,
Luis Diaz
(6)
,
Rudiger Eming
,
Sergei Grando
,
Russell Hall
,
Takashi Hashimoto
,
Josep Herrero-González
,
Michael Hertl
,
Pascal Joly
(7, 8)
,
Sarolta Karpati
,
Jaehwan Kim
,
Soo Chan Kim
,
Neil Korman
,
Cezary Kowalewski
,
Sang Eun Lee
,
David Rubenstein
,
Eli Sprecher
(9)
,
Kim Yancey
,
Giovanna Zambruno
(10)
,
Detlef Zillikens
,
Serge Doan
(11)
,
Benjamin Daniel
,
Victoria Werth
1
Service de dermatologie [Avicenne]
2 Department of Dermatology
3 UNIBE - Universität Bern [Bern]
4 ICA - Immunodermatologie, Cytokines, Cancer - EA 7319
5 Dermatology
6 XLIM-OSA - OSA
7 Service de dermatologie [Rouen]
8 PANTHER - Physiopathologie, Autoimmunité, maladies Neuromusculaires et THErapies Régénératrices
9 Laboratory of Molecular Dermatology and Department of Dermatology
10 Molecular and Cell Biology Laboratory
11 Service d'ophtalmologie [Hopital Bichat - Paris]
2 Department of Dermatology
3 UNIBE - Universität Bern [Bern]
4 ICA - Immunodermatologie, Cytokines, Cancer - EA 7319
5 Dermatology
6 XLIM-OSA - OSA
7 Service de dermatologie [Rouen]
8 PANTHER - Physiopathologie, Autoimmunité, maladies Neuromusculaires et THErapies Régénératrices
9 Laboratory of Molecular Dermatology and Department of Dermatology
10 Molecular and Cell Biology Laboratory
11 Service d'ophtalmologie [Hopital Bichat - Paris]
Dedee Murrell
- Function : Author
Branka Marinovic
- Function : Author
Catherine Prost
- Function : Author
Razzaque Ahmed
- Function : Author
Katarzyna Wozniak
- Function : Author
Masayuki Amagai
- Function : Author
Johann Bauer
- Function : Author
Donna Culton
- Function : Author
Janet Fairley
- Function : Author
David Fivenson
- Function : Author
Marcel Jonkman
- Function : Author
M Peter Marinkovich
- Function : Author
David Woodley
- Function : Author
John Zone
- Function : Author
Valeria Aoki
- Function : Author
Giuseppe Cianchini
- Function : Author
Vanessa Venning
- Function : Author
Rudiger Eming
- Function : Author
Sergei Grando
- Function : Author
Russell Hall
- Function : Author
Takashi Hashimoto
- Function : Author
Josep Herrero-González
- Function : Author
Michael Hertl
- Function : Author
Pascal Joly
- Function : Author
- PersonId : 944960
Sarolta Karpati
- Function : Author
Jaehwan Kim
- Function : Author
Soo Chan Kim
- Function : Author
Neil Korman
- Function : Author
Cezary Kowalewski
- Function : Author
Sang Eun Lee
- Function : Author
David Rubenstein
- Function : Author
Eli Sprecher
- Function : Author
- PersonId : 891343
Kim Yancey
- Function : Author
Detlef Zillikens
- Function : Author
Benjamin Daniel
- Function : Author
Victoria Werth
- Function : Author
Abstract
Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.